Target intelligence / Profile preview

Gluconokinase (IDNK)

Target
IDNK
Molecular classification
Enzyme, specifically kinase, Nucleoside/nucleotide kinase (superfamily)
01

Overview

Gluconokinase (IDNK) is an enzyme that catalyzes the phosphorylation of D-gluconate to 6-phospho-D-gluconate using ATP as a phosphate donor, generating ADP as a byproduct. It belongs to the kinase family, transferring a phosphate group specifically to carbohydrate substrates and participating in the pentose phosphate pathway, an alternative glucose metabolism pathway critical for nucleotide and amino acid biosynthesis. The human gene is found on chromosome 9, with the best-established activity predicted to be gluconokinase and involvement in carbohydrate metabolic processes. While orthologs are well-characterized in bacteria (such as E. coli idnK), the role of human gluconokinase is less well defined, with no established connection to common disease targets, known drugs, or biomarker applications. The enzyme acts on the metabolic level but is not currently considered a major therapeutic drug target.

Other names
Probable gluconokinaseC9orf103bA522I20.2hGntKGluconate kinasegluconokinase-like proteinidnKgluconokinase homologGluconate kinase 1D-gluconate kinasethermosensitive gluconokinaseECK4261gntVJW4225b4268
02

Mechanism of action

Not applicable/none established (no drugs known to target this enzyme directly in humans)

03

Biological functions

Carbohydrate metabolic process (specifically D-gluconate catabolism)ATP bindingcatalysis of phosphorylation (transfer of phosphate to D-gluconate)involvement in pentose phosphate pathway
04

Disease associations

Other (associated with rare disease Bejel in gene databases, but not established as central to major disease pathways)

Beyond the preview

Go deeper on Gluconokinase (IDNK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gluconokinase (IDNK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call